These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

796 related articles for article (PubMed ID: 24523438)

  • 21. Tumor-infiltrating Lymphocytes Predict the Chemotherapeutic Outcomes in Patients with Stage IV Colorectal Cancer.
    Shibutani M; Maeda K; Nagahara H; Fukuoka T; Iseki Y; Matsutani S; Kashiwagi S; Tanaka H; Hirakawa K; Ohira M
    In Vivo; 2018; 32(1):151-158. PubMed ID: 29275313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor Infiltrating T Lymphocytes and Apoptosis in Colorectal Cancer.
    Youssef MM; Paish EC; Murray JC; Farag NM; Saleh K; Ellis IO
    Egypt J Immunol; 2015; 22(1):19-28. PubMed ID: 26415369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic implications of tumor-infiltrating FoxP3+ regulatory T cells and CD8+ cytotoxic T cells in microsatellite-unstable gastric cancers.
    Kim KJ; Lee KS; Cho HJ; Kim YH; Yang HK; Kim WH; Kang GH
    Hum Pathol; 2014 Feb; 45(2):285-93. PubMed ID: 24331841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor-associated antigen recognized by the 22-1-1 monoclonal antibody encourages colorectal cancer progression under the scanty CD8+ T cells.
    Oshikiri T; Miyamoto M; Morita T; Fujita M; Miyasaka Y; Senmaru N; Yamada H; Takahashi T; Horita S; Kondo S
    Clin Cancer Res; 2006 Jan; 12(2):411-6. PubMed ID: 16428480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphocytic response to tumour and deficient DNA mismatch repair identify subtypes of stage II/III colorectal cancer associated with patient outcomes.
    Williams DS; Mouradov D; Jorissen RN; Newman MR; Amini E; Nickless DK; Teague JA; Fang CG; Palmieri M; Parsons MJ; Sakthianandeswaren A; Li S; Ward RL; Hawkins NJ; Faragher I; Jones IT; Gibbs P; Sieber OM
    Gut; 2019 Mar; 68(3):465-474. PubMed ID: 29382774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.
    Kim ST; Jeong H; Woo OH; Seo JH; Kim A; Lee ES; Shin SW; Kim YH; Kim JS; Park KH
    Am J Clin Oncol; 2013 Jun; 36(3):224-31. PubMed ID: 22495453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Predictive value of intraepithelial (CD3) T-lymphocyte infiltration in resected colorectal cancer].
    Borda F; Martínez-Peñuela JM; Borda A; Muñoz-Navas M; Jiménez J; Carretero C
    Gastroenterol Hepatol; 2012 Oct; 35(8):541-50. PubMed ID: 22858112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment Regimen, Surgical Outcome, and T-cell Differentiation Influence Prognostic Benefit of Tumor-Infiltrating Lymphocytes in High-Grade Serous Ovarian Cancer.
    Wouters MC; Komdeur FL; Workel HH; Klip HG; Plat A; Kooi NM; Wisman GB; Mourits MJ; Arts HJ; Oonk MH; Yigit R; de Jong S; Melief CJ; Hollema H; Duiker EW; Daemen T; de Bruyn M; Nijman HW
    Clin Cancer Res; 2016 Feb; 22(3):714-24. PubMed ID: 26384738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune infiltrates are prognostic factors in localized gastrointestinal stromal tumors.
    Rusakiewicz S; Semeraro M; Sarabi M; Desbois M; Locher C; Mendez R; Vimond N; Concha A; Garrido F; Isambert N; Chaigneau L; Le Brun-Ly V; Dubreuil P; Cremer I; Caignard A; Poirier-Colame V; Chaba K; Flament C; Halama N; Jäger D; Eggermont A; Bonvalot S; Commo F; Terrier P; Opolon P; Emile JF; Coindre JM; Kroemer G; Chaput N; Le Cesne A; Blay JY; Zitvogel L
    Cancer Res; 2013 Jun; 73(12):3499-510. PubMed ID: 23592754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor border configuration added to TNM staging better stratifies stage II colorectal cancer patients into prognostic subgroups.
    Zlobec I; Baker K; Minoo P; Hayashi S; Terracciano L; Lugli A
    Cancer; 2009 Sep; 115(17):4021-9. PubMed ID: 19517467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fusobacterium nucleatum and T Cells in Colorectal Carcinoma.
    Mima K; Sukawa Y; Nishihara R; Qian ZR; Yamauchi M; Inamura K; Kim SA; Masuda A; Nowak JA; Nosho K; Kostic AD; Giannakis M; Watanabe H; Bullman S; Milner DA; Harris CC; Giovannucci E; Garraway LA; Freeman GJ; Dranoff G; Chan AT; Garrett WS; Huttenhower C; Fuchs CS; Ogino S
    JAMA Oncol; 2015 Aug; 1(5):653-61. PubMed ID: 26181352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic impact of tumour-infiltrating B cells and plasma cells in colorectal cancer.
    Berntsson J; Nodin B; Eberhard J; Micke P; Jirström K
    Int J Cancer; 2016 Sep; 139(5):1129-39. PubMed ID: 27074317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancer.
    Zlobec I; Minoo P; Baumhoer D; Baker K; Terracciano L; Jass JR; Lugli A
    Cancer; 2008 Feb; 112(3):495-502. PubMed ID: 18076013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of CD3+ tumor-infiltrating lymphocytes in patients with endometrial carcinoma.
    Čermáková P; Melichar B; Tomšová M; Zoul Z; Kalábová H; Spaček J; Doležel M
    Anticancer Res; 2014 Oct; 34(10):5555-61. PubMed ID: 25275055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The role of CDDP on cytotoxicity of TILs obtained from colorectal tumors].
    Xu Z; Qi X; Liu F
    Zhonghua Wai Ke Za Zhi; 1997 May; 35(5):265-7. PubMed ID: 10374556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fas ligand and tumour counter-attack in colorectal cancer stratified according to microsatellite instability status.
    Michael-Robinson JM; Pandeya N; Cummings MC; Walsh MD; Young JP; Leggett BA; Purdie DM; Jass JR; Radford-Smith GL
    J Pathol; 2003 Sep; 201(1):46-54. PubMed ID: 12950016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel expression of Neuropilin 1 on human tumor-infiltrating lymphocytes in colorectal cancer liver metastases.
    Chaudhary B; Elkord E
    Expert Opin Ther Targets; 2015 Feb; 19(2):147-61. PubMed ID: 25351619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma.
    Tomsová M; Melichar B; Sedláková I; Steiner I
    Gynecol Oncol; 2008 Feb; 108(2):415-20. PubMed ID: 18037158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccination with autologous tumor-derived heat-shock protein gp96 after liver resection for metastatic colorectal cancer.
    Mazzaferro V; Coppa J; Carrabba MG; Rivoltini L; Schiavo M; Regalia E; Mariani L; Camerini T; Marchianò A; Andreola S; Camerini R; Corsi M; Lewis JJ; Srivastava PK; Parmiani G
    Clin Cancer Res; 2003 Aug; 9(9):3235-45. PubMed ID: 12960108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The essential role of the in situ immune reaction in human colorectal cancer.
    Pagès F; Galon J; Fridman WH
    J Leukoc Biol; 2008 Oct; 84(4):981-7. PubMed ID: 18559950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.